Desmopressin plus tolterodine versus desmopressin plus indomethacin for pediatric enuresis

Phase 2

Completed

• Conditions: Pediatric enuresis.; Nocturnal enuresis; N39.44

• Registration Number: IRCT20210613051564N1

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-08-30

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age >5 years and <18 years
Diagnosis of mono- or disymptomatic enuresis

Exclusion Criteria

Having previously received any treatment for enuresis
Secondary causes of enuresis, including anatomic disorders of the urinary system, trauma, constipation, diabetes mellitus, diabetes insipidus, urinary tract infection, and the like.

Study & Design

• Study Type: interventional
• Study Design: Not specified